Stereotaxis (NYSE: STXS) insider transactions
In the twelve months to 10 November 2026, executives and directors of Stereotaxis reported 0 open-market sales and 2 open-market purchases of 30,000 shares ($66,600), by 1 person, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 1 July 2026 | Menawat Arun Swarup | Director | Grant or award | +43,103 | — | 1,035,560 | Form 4 |
| 1 July 2026 | Curet Myriam | Director | Grant or award | +43,103 | — | 435,161 | Form 4 |
| 1 July 2026 | Fischel Nathan | Director | Grant or award | +43,103 | — | 720,775 | Form 4 |
| 1 July 2026 | Levin Ross B | Director | Grant or award | +43,103 | — | 621,248 | Form 4 |
| 1 July 2026 | Benfer David | Director | Grant or award | +43,103 | — | 558,975 | Form 4 |
| 1 July 2026 | Shamir Nachum | Director | Grant or award | +43,103 | — | 179,327 | Form 4 |
| 2 January 2026 | Shamir Nachum | Director | Grant or award | +46,948 | — | 136,224 | Form 4 |
| 2 January 2026 | Levin Ross B | Director | Grant or award | +46,948 | — | 578,145 | Form 4 |
| 2 January 2026 | Fischel Nathan | Director | Grant or award | +46,948 | — | 677,672 | Form 4 |
| 2 January 2026 | Benfer David | Director | Grant or award | +46,948 | — | 515,872 | Form 4 |
| 2 January 2026 | Menawat Arun Swarup | Director | Grant or award | +46,948 | — | 992,457 | Form 4 |
| 2 January 2026 | Curet Myriam | Director | Grant or award | +46,948 | — | 392,058 | Form 4 |
| 17 November 2025 | Isaac Paul J | Director | Open-market purchase | +10,000 | $2.18 | 97,299 | Form 4 |
| 14 November 2025 | Isaac Paul J | Director | Open-market purchase | +20,000 | $2.24 | 2,786,557 | Form 4 |
| 1 July 2025 | Shamir Nachum | Director | Grant or award | +43,668 | — | 89,276 | Form 4 |
| 1 July 2025 | Curet Myriam | Director | Grant or award | +43,668 | — | 345,110 | Form 4 |
| 1 July 2025 | Benfer David | Director | Grant or award | +43,668 | — | 468,924 | Form 4 |
| 1 July 2025 | Levin Ross B | Director | Grant or award | +43,668 | — | 531,197 | Form 4 |
| 1 July 2025 | Fischel Nathan | Director | Grant or award | +43,668 | — | 630,724 | Form 4 |
| 1 July 2025 | Menawat Arun Swarup | Director | Grant or award | +43,668 | — | 945,509 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Stereotaxis page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.